Cited by 403Ubiquitin and proteasome pathwaysCancer-related Molecular PathwaysWnt/β-catenin signaling in development and cancer

The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase

Open access
Wei, Wenyi, Jin, Jianping, Schlisio, Susanne, Harper, J. Wade, Kaelin, William G.·2005·Cancer Cell

Abstract

The c-Jun and c-Myc oncogenic transcription factors are highly unstable proteins due to polyubiquitination. Similar to c-Myc, we report here that phosphorylation of c-Jun by GSK3 creates a high-affinity binding site for the E3 ligase Fbw7, which targets c-Jun for polyubiquitination and proteasomal degradation. In keeping with this, we found that c-Jun levels were inversely related to GSK3 activity in mammalian cells that had entered the cell cycle. Importantly, phosphorylation of c-Jun by GSK3 requires a priming phosphorylation event at Ser-243. Ser-243 is mutated to phenylalanine in v-Jun and allows it to escape recognition by Fbw7. These findings explain the enhanced stability and oncogenicity of v-Jun relative to its cellular counterpart and reveal that GSK3 and Fbw7 coordinately regulate c-Jun and c-Myc.

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2005.06.005

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PU.1 phosphorylation by GSK creates a high-affinity binding site for FBW7, which targets PU.1 but not interaction-resistant PU.1-S41,S140A for polyubiquitination and proteasomal degradation.

    “It appears that like in case of other GSK3 substrates (17), PU.1 phosphorylation by GSK apparently creates highaffinity binding site for FBW7 which eventually targets PU.1 but not the interaction-resistant PU.1-S41, S141A for polyubiquitination and proteasomal degradation.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wei, W., Jin, J., Schlisio, S., Harper, J. W., & Kaelin, W. G.
Affiliations
  • Brigham and Women's Hospital (US)
  • Harvard University (US)
Corresponding author
Kaelin, William G.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2005-07
Volume
8
Issue
1
Pages
25-33
ISSN
1535-6108 (ISSN-L)
OpenAlex
W2034375388
Cited by
403
References
37
Citations by year
2026: 8 · 2025: 6 · 2024: 9 · 2023: 11 · 2022: 26 · 2021: 10 · 2020: 23 · 2019: 12 · 2018: 17 · 2017: 24 · 2016: 13 · 2015: 20 · 2014: 26 · 2013: 27 · 2012: 25
FWCI
8.97
Type
journal article
Language
en
Open access
Locations
  • Cancer Cell (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (AG11085, R01AG011085)
  • National Cancer Institute (R01CA076120)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
Keywords
c-Jun, v-Jun, glycogen synthase kinase-3, FBXW7, ubiquitin ligase, protein phosphorylation, polyubiquitination, proteasomal degradation, protein stability, c-Myc, oncogenic transcription factor, cell cycle
MeSH terms
F-Box-WD Repeat-Containing Protein 7, Binding Sites, Cell Cycle, Cells, Cultured, Enzyme Inhibitors, Humans, Ligases, Phenylalanine, Phosphorylation, Serine, Proto-Oncogene Proteins c-myc, Proto-Oncogene Proteins c-jun, Oncogene Protein p65(gag-jun), Point Mutation, Cell Cycle Proteins, Ubiquitin, RNA, Small Interfering, Glycogen Synthase Kinase 3, Ubiquitin-Protein Ligases, F-Box Proteins, Proteasome Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review